127 related articles for article (PubMed ID: 38059315)
1. Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine.
Wang Z; Gao Y; Ji X; Wu T; Pu L; Qiu W
J Clin Pharmacol; 2024 May; 64(5):601-608. PubMed ID: 38059315
[TBL] [Abstract][Full Text] [Related]
2. Impacts of Cytochrome P450 2D6*10 Allele and a High-Fat Meal on the Pharmacokinetics of Dapoxetine in Healthy Chinese Men: A Single-Dose, Two-Treatment Study.
Tang S; Zhao P; Zheng L; Wen C; Wang L; Jiang X
Adv Ther; 2019 Aug; 36(8):2096-2105. PubMed ID: 31148055
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of dapoxetine hydrochloride in healthy Chinese, Japanese, and Caucasian men.
Thyssen A; Sharma O; Tianmei S; Aquilina JW; Vandebosch A; Wang SS; Mudumbi R; Hsiao HL
J Clin Pharmacol; 2010 Dec; 50(12):1450-60. PubMed ID: 20097934
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
[TBL] [Abstract][Full Text] [Related]
5. Effects of Grapefruit and Pomegranate Juices on the Pharmacokinetic Properties of Dapoxetine and Midazolam in Healthy Subjects.
Abdlekawy KS; Donia AM; Elbarbry F
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):397-405. PubMed ID: 27294349
[TBL] [Abstract][Full Text] [Related]
6. Effects of 22 novel CYP2D6 variants found in Chinese population on the metabolism of dapoxetine.
Xu RA; Gu EM; Zhou Q; Yuan L; Hu X; Cai J; Hu G
Drug Des Devel Ther; 2016; 10():687-96. PubMed ID: 26937172
[TBL] [Abstract][Full Text] [Related]
7. Dapoxetine and the treatment of premature ejaculation.
Sangkum P; Badr R; Serefoglu EC; Hellstrom WJ
Transl Androl Urol; 2013 Dec; 2(4):301-11. PubMed ID: 26816743
[TBL] [Abstract][Full Text] [Related]
8. Influence of CYP2D6*5 and *10 polymorphism on the pharmacokinetics of nebivolol in healthy Chinese subjects.
Guo L; Wang S; Wan Z; Ni S; Xu B; Zhao X; Liu L
J Clin Pharm Ther; 2020 Aug; 45(4):632-637. PubMed ID: 32379356
[TBL] [Abstract][Full Text] [Related]
9. Dapoxetine for premature ejaculation.
McMahon CG
Expert Opin Pharmacother; 2010 Jul; 11(10):1741-52. PubMed ID: 20540653
[TBL] [Abstract][Full Text] [Related]
10. Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes.
Byeon JY; Lee YJ; Kim YH; Kim SH; Lee CM; Bae JW; Jang CG; Lee SY; Choi CI
Arch Pharm Res; 2018 May; 41(5):564-570. PubMed ID: 29728928
[TBL] [Abstract][Full Text] [Related]
11. Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers.
Pawlowska M; Bogiel M; Duda J; Sieradzki E
Eur J Clin Pharmacol; 2015 Jun; 71(6):699-705. PubMed ID: 25953735
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems.
Chen R; Wang H; Shi J; Shen K; Hu P
Eur J Clin Pharmacol; 2015 Jul; 71(7):835-41. PubMed ID: 25967538
[TBL] [Abstract][Full Text] [Related]
13. Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation.
Modi NB; Dresser MJ; Simon M; Lin D; Desai D; Gupta S
J Clin Pharmacol; 2006 Mar; 46(3):301-9. PubMed ID: 16490806
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers.
Kim YH; Choi HY; Lee SH; Jeon HS; Lim HS; Bahng MY; Bae KS
Drug Des Devel Ther; 2015; 9():1209-16. PubMed ID: 25759565
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive assessment of genetic variation in serotonin transporter gene (5-HTTLPR+rs25531) and the response to dapoxetine in Chinese patients with premature ejaculation.
Huang Y; Gao J; Gao P; Peng D; Dai Y; Jiang H; Zhang X
Andrologia; 2021 Sep; 53(8):e14141. PubMed ID: 34118072
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Safety of Dapoxetine Hydrochloride in Healthy Chinese Men: Impact of Dose and High-Fat Meal.
Liu J; Li Z; Yan K; Ju G; Qiu W
Clin Pharmacol Drug Dev; 2021 Oct; 10(10):1216-1224. PubMed ID: 33528113
[TBL] [Abstract][Full Text] [Related]
17. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case.
Waldinger MD; Schweitzer DH
J Sex Med; 2008 Apr; 5(4):966-997. PubMed ID: 18371047
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review.
Russo A; Capogrosso P; Ventimiglia E; La Croce G; Boeri L; Montorsi F; Salonia A
Int J Clin Pract; 2016 Sep; 70(9):723-33. PubMed ID: 27456527
[TBL] [Abstract][Full Text] [Related]
19. Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes.
Jung EH; Lee YJ; Kim DH; Kang P; Lim CW; Cho CK; Jang CG; Lee SY; Bae JW
Arch Pharm Res; 2020 Dec; 43(12):1356-1363. PubMed ID: 33245517
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects.
Shin D; Lee S; Yi S; Yoon SH; Cho JY; Bahng MY; Jang IJ; Yu KS
Drug Des Devel Ther; 2017; 11():713-723. PubMed ID: 28331291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
